Clinical Trials for Type 2 Diabetes

Type 2 diabetes affects more than 37 million Americans and is the most common form of diabetes worldwide. Despite effective existing medications, many patients struggle with blood sugar control, side effects, or disease progression. Clinical trials are testing next-generation GLP-1 receptor agonists, dual and triple hormone agonists, beta-cell regeneration therapies, and intensive lifestyle programs that may dramatically improve outcomes for people living with T2DM.

Find Type 2 Diabetes Trials Near You

Search actively recruiting studies — filter by your state, age, and HbA1c range. Free access, updated daily from ClinicalTrials.gov.

Search Type 2 Diabetes Trials →
Data Source
ClinicalTrials.gov
Updated
Daily
Filter By
Location, Phase, Age
Cost to Search
Free

What to Expect as a Participant

Common Questions

What kinds of Type 2 diabetes trials are available?

Trials test a wide range of interventions: new oral medications (SGLT2 inhibitors, DPP-4 inhibitors), injectable therapies (GLP-1 and GIP agonists), weight-loss surgeries, dietary programs, and digital health apps that pair with glucose monitors.

Will I have to stop my current diabetes medications?

Not necessarily. Some trials require a washout period before enrollment; others allow or even require background metformin or other agents. The protocol will specify exactly what medications are allowed — ask the study coordinator before screening.

Are trials safe for older adults with diabetes?

Many trials specifically recruit older adults (65+) and have age-appropriate eligibility criteria. Safety monitoring is continuous, and you can withdraw at any time without losing access to standard care.

How long do diabetes trials last?

Duration varies widely — from 12-week lifestyle studies to multi-year cardiovascular outcome trials. The listing will include estimated completion dates and visit schedules so you can plan accordingly.